Provided herein are compositions and methods for the treatment of obesity and related disorders, including, but not limited to insulin resistance, diabetes, and hepatic steatosis. For example, in some embodiments, pharmaceutically acceptable compositions and methods are provided employing amlexanox, a derivative thereof, or a pharmaceutically acceptable salt thereof, alone or in combination with other agents and/or medical interventions, for the treatment, prevention, and management of such dise...

A method for treating canker sores with oral patches to speed healing and relieve pain. If certain medications are applied to a canker sore using an oral patch that restricts local flow of saliva and delivers the medication for at least 30 minutes and the patches are used for at least two or more hours per day the method reduces the healing time for canker sores from typical 10 - 14 days to 2 days. The method can be used with various antimicrobials that speed the healing of canker sores includin...

An agent, which is amlexanox, is useful in the therapy of a disease associated with neutrophilia.

Uso de i) una sustancia fisiológicamente activa seleccionada del grupo que consiste en un analgésico un agente antiinflamatorio un DMARD un inhibidor de la degradación de cartílago un inmunomodulador un inmunosupresor un agente antialérgico un inhibidor de resorción ósea y un antioxidante y ii) un polímero biocompatible que permite una liberación sostenida de la sustancia fisiológicamente activa para la preparación de una nanocápsula para administración intra-articular para el trata...

An agent which is amlexanox is useful in the therapy of a disease associated with neutrophilia.

PROBLEM TO BE SOLVED: To provide a new medical composition having an airway goblet cell hyperplasia inhibitory action particularly useful for prevention and treatment of respiratory tract diseases further for prevention and treatment of such as cold. SOLUTION: No single medicine exhibits airway goblet cell hyperplasia inhibitory action however a new expression of the airway goblet cell hyperplasia inhibitory action was found by the combination of amlexanox and ephedrines and the task was solved...